Details

Autor(en) / Beteiligte

• Levine, Edward A.
• Rosen, Arthur L.
• Sehgal, Lakshman R.
• Gould, Steven A.
• Sehgal, Hansa L.
• Moss, Gerald S.

Titel

Physiologic effects of acute anemia: implications for a reduced transfusion trigger

Ist Teil von

• Transfusion (Philadelphia, Pa.), 1990-01, Vol.30 (1), p.11-14

Ort / Verlag

Edinburgh, UK: Blackwell Science Ltd

Erscheinungsjahr

1990

Quelle

MEDLINE

Beschreibungen/Notizen

• The risks of transfusion‐associated infectious disease have led to a reassessment of transfusion practice, which in turn has resulted in a trend toward the reduction of homologous transfusion. This reduction is primarily due to the initiation of hemotherapy at more severe levels of anemia. The optimum threshold for the initiation of transfusion therapy, or the transfusion trigger (TT), is unknown. The purpose of this study is to evaluate the effects of withholding transfusion or lowering the TT to a hematocrit (Hct) of 15 percent in unanesthetized animals. Nineteen adult baboons underwent a laparotomy to simulate surgical stress. Upon their recovery from anesthesia, hemodynamic measurements were obtained, and the animals underwent an exchange transfusion (ET) with 6‐percent hetastarch to a final Hct of 15 percent. After ET, hemodynamic measurements were repeated, and the animals were followed for 2 months. There was no morbidity after ET or during the 2‐month observation period. After ET, there was a significant increase in both the cardiac output (3.3 vs. 2.5 L/min, p less than 0.001) and the oxygen extraction ratio (59.9 vs. 38.2%, p less than 0.0001). Oxygen delivery fell after ET (18.9 vs. 11.1 cc/kg/min, p less than 0.001), but there was no significant change in oxygen consumption after ET. The unanesthetized animals adapted well to severe anemia and experienced no adverse effects on their long‐term survival in this setting, which suggests that the reduction of the TT to a Hct of 15 percent in normal animals is safe. Adoption of this TT could result in a significant reduction in the requirements for homologous transfusion with its attendant risks.